A Mendelian randomization study of circulating uric acid and type 2 diabetes

Diabetes

Volumn 64, Issue 8, 2015, Pages 3028-3036

  Sluijs, Ivonne ^a   Holmes, Michael V ^b,c   Van Der Schouw, Yvonne T ^a   Beulens, Joline W J ^a   Asselbergs, Folkert W ^a,d   Huerta, José María ^e,f   Palmer, Tom M ^g   Arriola, Larraitz ^f,h,i   Balkau, Beverley ^j,k   Barricarte, Aurelio ^f,l   Boeing, Heiner ^m   Clavel Chapelon, Françoise ^j,k   Fagherazzi, Guy ^j,k   Franks, Paul W ^n,o   Gavrila, Diana ^e,f   Kaaks, Rudolf ^p   Khaw, Kay Tee ^q   Kühn, Tilman ^p   Molina Montes, Esther ^f,r   Mortensen, Lotte Maxild ^s,t   Nilsson, Peter M ⁿ   Overvad, Kim ^s,t   Palli, Domenico ^u   Panico, Salvatore ^v   Quirós, J Ramón ^w   Rolandsson, Olov ^o   Sacerdote, Carlotta ^x,y   Sala, Núria ^z   Schmidt, Julie A ^b   Scott, Robert A ^q   Sieri, Sabina ^aa   Slimani, Nadia ^ab   Spijkerman, Annemieke M W ^ac   Tjonneland, Anne ^ad   Travis, Ruth C ^b   Tumino, Rosario ^ae,af   Van Der Daphne, L A ^ac   Sharp, Stephen J ^q   Forouhi, Nita G ^q   Langenberg, Claudia ^q   Riboli, Elio ^ag   Wareham, Nicholas J ^q   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h Basque Government   (Spain)

ⁱ BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^j CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^m GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁿ LUND UNIVERSITY   (Sweden)

^o UMEÅ UNIVERSITY   (Sweden)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^s AALBORG UNIVERSITY HOSPITAL   (Denmark)

^t AARHUS UNIVERSITY   (Denmark)

^u CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^v UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^w Public Health Directorate   (Spain)

^x UNIVERSITY OF TURIN   (Italy)

^y Human Genetics Foundation (HuGeF)   (Italy)

^z CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^aa Epidemiology Unit   (Italy)

^ab INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ac NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ad DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ae Cancer Registry and Histopathology Unit Civic MP Arezzo Hospita   (Italy)

^af Aire Onlus   (Italy)

^ag IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ATAXIN 2; BREAST CANCER RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER 4; SODIUM PHOSPHATE COTRANSPORTER 1; TRANSCRIPTION FACTOR MAF; TRIACYLGLYCEROL; URATE TRANSPORTER; URIC ACID;

ADULT; AGED; ARTICLE; BAZ1B GENE; BCAS3 GENE; BODY MASS; FEMALE; FOLLOW UP; GCKR GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IGF1R GENE; INHBC GENE; LRRC16A GENE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MULTICENTER STUDY; NFAT5 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORC4L GENE; OVOL1 GENE; PDZK1 GENE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PRKAG2 GENE; RISK ASSESSMENT; RREB1 GENE; SFMBT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC16A9 GENE; SLC2A9 GENE; STC1 GENE; TRIACYLGLYCEROL BLOOD LEVEL; UBE2Q2 GENE; VEGFA GENE; VITAMIN INTAKE; BLOOD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URIC ACID;

EID: 84943357645     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0742     Document Type: Article

References (42)

1. Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009;32:1737-1742
2. Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One 2013;8:e56864
3. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359:1811-1821
4. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006;55:1293-1301
5. Ogino K, Kato M, Furuse Y, et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81
6. Perez-Pozo SE, Schold J, Nakagawa T, Sánchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010;34:454-461
7. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006;114:2508-2516
8. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42
9. Kolz M, Johnson T, Sanna S, et al.; EUROSPAN Consortium; ENGAGE Consortium; PROCARDIS Consortium; KORA Study; WTCCC. Meta-analysis of 28, 141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009;5:e1000504
10. Köttgen A, Albrecht E, Teumer A, et al.; LifeLines Cohort Study; CARDIoGRAM Consortium; DIAGRAM Consortium; ICBP Consortium; MAGIC Consortium. Genomewide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013;45:145-154
11. Yang Q, Köttgen A, Dehghan A, et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010;3:523-530
12. Pfister R, BarnesD, Luben R, et al. No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia 2011;54:2561-2569
13. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163
14. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(Suppl. 1):S6-S14
15. Langenberg C, Sharp S, Forouhi NG, et al.; InterAct Consortium. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011;54:2272-2282
16. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-413
17. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
18. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11
19. Palmer TM, Sterne JA, Harbord RM, et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 2011;173:1392-1403
20. Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 2013;42:1497-1501
21. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005
22. Morris AP, Voight BF, Teslovich TM, et al.; Wellcome Trust Case Control Consortium; Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators; Genetic Investigation of ANthropometric Traits (GIANT) Consortium; Asian Genetic Epidemiology Network-Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990
23. Thomas DC, Lawlor DA, Thompson JR. Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol 2007;17:511-513
24. McKeigue PM, Campbell H, Wild S, et al. Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome. Int J Epidemiol 2010;39:907-918
25. Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol 2013;28:669-676
26. Palmer TM, Nordestgaard BG, Benn M, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 2013;347:f4262
27. Oikonen M, Wendelin-Saarenhovi M, Lyytikäinen LP, et al. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study. Atherosclerosis 2012;223:497-503
28. Lyngdoh T, Vuistiner P, Marques-Vidal P, et al. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS One 2012;7:e39321
29. Rasheed H, Hughes K, Flynn TJ, Merriman TR. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ Cardiovasc Genet 2014;7:830-837
30. Parsa A, Brown E, Weir MR, et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 2012;81:502-507
31. Sedaghat S, Pazoki R, Uitterlinden AG, et al. Association of uric acid genetic risk score with blood pressure: the Rotterdam study. Hypertension 2014;64:1061-1066
32. Mallamaci F, Testa A, Leonardis D, et al. A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study. J Hypertens 2014;32:1621-1628; discussion 1628
33. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334
34. DeBosch BJ, Kluth O, Fujiwara H, Schürmann A, Moley K. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat Commun 2014;5:4642
35. Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009;30:96-116
36. Holmes MV, Asselbergs FW, Palmer TM, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J 2015;36:539-350
37. Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 2012;3:764
38. Davey Smith G. Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference. Epidemiology 2011;22:460-463; discussion 467-468
39. Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 2010;1212:59-77
40. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through largescale association analysis. Nat Genet 2010;42:579-589
41. Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008;40:437-442
42. Caulfield MJ, Munroe PB, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008;5:e197